Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai population

Neuroscience Letters

Volumn 551, Issue , 2013, Pages 58-61

  Chanasong, Rachanee ^a   Thanoi, Samur ^a   Watiktinkorn, Paritat ^b   Reynolds, Gavin P ^c   Nudmamud Thanoi, Sutisa ^a  

^a NARESUAN UNIVERSITY   (Thailand)

^b Synphaet Hospital   (Thailand)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

GRIN1; Methamphetamine; Pharmacogenetics; Psychosis; Substance misuse

Indexed keywords

GRIN1 PROTEIN; METHAMPHETAMINE; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; THAILAND;

GRIN1; METHAMPHETAMINE; PHARMACOGENETICS; PSYCHOSIS; SUBSTANCE MISUSE;

ADULT; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC; PSYCHOSES, SUBSTANCE-INDUCED; RECEPTORS, N-METHYL-D-ASPARTATE; RISK FACTORS; THAILAND; YOUNG ADULT;

EID: 84882247303     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.07.017     Document Type: Article

References (41)

1. American Psychiatric Association Diagnosis and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Akiyama K., Kanzaki A., Tsuchida K., Ujike H. Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophrenia Research 1994, 12(3):251-257.
3. Begni S., Moraschi S., Bignotti S., Fumagalli F., Rillosi L., Perez J., Gennarelli M. Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biological Psychiatry 2003, 53(7):617-619.
4. Bousman C.A., Glatt S.J., Cherner M., Atkinson J.H., Grant I., Tsuang M.T., Everall I.P. Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Research 2010, 178(2):295-298.
5. Featherstone R.E., Kapur S., Fletcher P.J. The amphetamine-induced sensitized state as a model of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31(8):1556-1571.
6. Galehdari H., Pooryasin A., Foroughmand A., Daneshmand S., Saadat M. Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. Journal of Molecular Neuroscience 2009, 38(2):178-181.
7. Georgi A., Jamra R.A., Klein K., Villela A.W., Schumacher J., Becker T., Paul T., Schmael C., Hofels S., Klopp N., Illig T., Propping P., Cichon S., Nothen M.M., Schulze T.G., Rietschel M. Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample. Psychiatric Genetics 2007, 17(45):308-310.
8. Goebel D.J., Poosch M.S. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. Brain Research. Molecular Brain Research 1999, 69(2):164-170.
9. Hirasawa T., Wada H., Kohsaka S., Uchino S. Inhibition of NMDA receptors induces delayed neuronal maturation and sustained proliferation of progenitor cells during neocortical development. Journal of Neuroscience Research 2003, 74(5):676-687.
10. Kalivas P.W., Lalumiere R.T., Knackstedt L., Shen H. Glutamate transmission in addiction. Neuropharmacology 2009, 56(Supplement 1):169-173.
11. Kerdsan W., Thanoi S., Nudmamud-Thanoi S. Changes in glutamate/NMDA receptor subunit 1 expression in rat brain after acute and subacute exposure to methamphetamine. Journal of Biomedicine & Biotechnology 2009, 2009. Article ID 329631, 4 pages.
12. Kiefer F., Jahn H., Koester A., Montkowski A., Reinscheid R.K., Wiedemann K. Involvement of NMDA receptors in alcohol-mediated behavior: mice with reduced affinity of the NMDA R1 glycine binding site display an attenuated sensitivity to ethanol. Biological Psychiatry 2003, 53(4):345-351.
13. Kishimoto M., Ujike H., Motohashi Y., Tanaka Y., Okahisa Y., Kotaka T., Harano M., Inada T., Yamada M., Komiyama T., Hori T., Sekine Y., Iwata N., Sora I., Iyo M., Ozaki N., Kuroda S. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biological Psychiatry 2008, 63(2):191-196.
14. Kotaka T., Ujike H., Okahisa Y., Takaki M., Nakata K., Kodama M., Inada T., Yamada M., Uchimura N., Iwata N., Sora I., Iyo M., Ozaki N., Kuroda S. G72 gene is associated with susceptibility to methamphetamine psychosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009, 33(6):1046-1049.
15. Laube B., Kuhse J., Betz H. Evidence for a tetrameric structure of recombinant NMDA receptors. Journal of Neuroscience 1998, 18(8):2954-2961.
16. Lu W., Monteggia L.M., Wolf M.E. Withdrawal from repeated amphetamine administration reduces NMDAR1 expression in the rat substantia nigra, nucleus accumbens and medial prefrontal cortex. The European Journal of Neuroscience 1999, 11(9):3167-3177.
17. Machiyama Y. Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophrenia Bulletin 1992, 18(1):107-113.
18. Madry C., Mesic I., Bartholomaus I., Nicke A., Betz H., Laube B. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function. Biochemical and Biophysical Research Communications 2007, 354(1):102-108.
19. Marshall J.F., O'Dell S.J., Weihmuller F.B. Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. Journal of Neural Transmission. General Section 1993, 91(2-3):241-254.
20. Nordahl T.E., Salo R., Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. The Journal of Neuropsychiatry and Clinical Neurosciences 2003, 15(3):317-325.
21. Nudmamud S., Reynolds G.P. Increased density of glutamate/N-methyl-d-aspartate receptors in superior temporal cortex in schizophrenia. Neuroscience Letters 2001, 304(1-2):9-12.
22. Nudmamud-Thanoi S., Piyabhan P., Harte M.K., Cahir M., Reynolds G.P. Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia. Journal of Neural Transmission. Supplementa 2007, 72:281-285.
23. Paus S., Rietschel M., Schulze T.G., Ohlraun S., Diaconu C.C., Van Den Bogaert A., Maier W., Propping P., Cichon S., Nothen M.M. Systematic screening for mutations in the human N-methyl-d-aspartate receptor 1 gene in schizophrenic patients from the German population. Psychiatric Genetics 2004, 14(4):233-234.
24. Paz R.D., Tardito S., Atzori M., Tseng K.Y. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. European Neuropsychopharmacology 2008, 18(11):773-786.
25. Qin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., Bao J., Zhang Z., He L. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. European Journal of Human Genetics 2005, 13(7):807-814.
26. Riedel G., Platt B., Micheau J. Glutamate receptor function in learning and memory. Behavioural Brain Research 2003, 140(1-2):1-47.
27. Rujescu D., Soyka M., Dahmen N., Preuss U., Hartmann A.M., Giegling I., Koller G., Bondy B., Moller H.J., Szegedi A. GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics 2005, 133B(1):85-87.
28. Saadat M. N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) G1001C polymorphism and susceptibility to schizophrenia: a meta-analysis. Experimental and Clinical Sciences International Journal 2010, 9:11-16.
29. Sakurai K., Toru M., Yamakawa-Kobayashi K., Arinami T. Mutation analysis of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neuroscience Letters 2000, 296(2-3):168-170.
30. Schuler T., Mesic I., Madry C., Bartholomaus I., Laube B. Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-d-aspartate receptor assembly. The Journal of Biological Chemistry 2008, 283(1):37-46.
31. Simões P.F., Silva A.P., Pereira F.C., Marques E., Milhazes N., Borges F., Ribeiro C.F., Macedo T.R. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Annals of the New York Academy of Sciences 2008, 1139:232-241.
32. Tamminga C.A., Lahti A.C., Medoff D.R., Gao X.M., Holcomb H.H. Evaluating glutamatergic transmission in schizophrenia. Annals of the New York Academy of Sciences 2003, 1003:113-118.
33. Tzschentke T.M., Schmidt W.J. Glutamatergic mechanisms in addiction. Molecular Psychiatry 2003, 8(4):373-382.
34. Uhl G.R., Drgon T., Liu Q.R., Johnson C., Walther D., Komiyama T., Harano M., Sekine Y., Inada T., Ozaki N., Iyo M., Iwata N., Yamada M., Sora I., Chen C.K., Liu H.C., Ujike H., Lin S.K. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Archives of General Psychiatry 2008, 65(3):345-355.
35. Ujike H., Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Annals of the New York Academy of Sciences 2004, 1025:279-287.
36. Vengeliene V., Bilbao A., Molander A., Spanagel R. Neuropharmacology of alcohol addiction. British Journal of Pharmacology 2008, 154(2):299-315.
37. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Molecular Psychiatry 2004, (9):557-569.
38. Wernicke C., Samochowiec J., Schmidt L.G., Winterer G., Smolka M., Kucharska-Mazur J., Horodnicki J., Gallinat J., Rommelspacher H. Polymorphisms in the N-methyl-d-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Biological Psychiatry 2003, 54(9):922-928.
39. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., Schmunk G.A., Shannak K., Haycock J.W., Kish S.J. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine 1996, 2(6):699-703.
40. Yamamoto H., Kitamura N., Lin X.H., Ikeuchi Y., Hashimoto T., Shirakawa O., Maeda K. Differential changes in glutamatergic transmission via N-methyl-d-aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 1999, 2(3):155-163.
41. Zhao X., Li H., Shi Y., Tang R., Chen W., Liu J., Feng G., Shi J., Yan L., Liu H., He L. Significant association between the genetic variations in the 5' end of the N-methyl-d-aspartate receptor subunit gene GRIN1 and schizophrenia. Biological Psychiatry 2006, 59(8):747-753.